• Filing Date: 2019-08-13
  • Form Type: 10-Q
  • Description: Quarterly report
v3.19.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 4,781,520 $ 2,386,314
Short-term investment securities 32,104,149 38,816,441
Interest receivable 399,242 294,240
Accounts receivable 504,510 318,744
Income tax receivable 0 506,866
Prepaid research and development 98,924 253,446
Prepaid expenses and other current assets 112,136 172,001
Total current assets 38,000,481 42,748,052
Non-current assets:    
Long-term investment securities 1,516,670 0
Long-term income tax receivable 500,616 500,616
Other assets 51,575 52,139
Total assets 40,069,342 43,300,807
Current liabilities:    
Accounts payable 963,264 309,060
Accrued expenses 396,041 399,576
Deferred research and development obligations 90,572 141,002
Total current liabilities 1,449,877 849,638
Commitments and contingencies (See Note 4)
Stockholders' equity:    
Preferred stock 0 0
Common stock 39,365 38,967
Additional paid-in capital 95,424,178 94,385,230
Treasury stock, shares held at cost (18,929,915) (18,929,915)
Accumulated deficit (37,914,163) (33,043,113)
Total stockholders’ equity 38,619,465 42,451,169
Total liabilities and stockholders’ equity $ 40,069,342 $ 43,300,807